Research suggests a modest and indirect link between moderate red wine consumption and cholesterol management, though the available evidence here is limited and largely observational. A 2020 analysis of UK Biobank data found that red wine consumption was associated with a modestly reduced risk of SARS-CoV-2 infection, and the authors proposed this relationship may be partly explained by red wine's known tendency to raise HDL ("good") cholesterol levels — though the study was not designed to test red wine's effects on cholesterol directly. A separate 2025 brain imaging and metabolic study from the same biobank database examined depression and metabolic dysfunction and found that lower HDL levels are a persistent feature of certain chronic conditions, underscoring HDL's broader relevance to health, though this study did not examine red wine at all. Both studies are observational in nature, meaning they can identify associations but cannot establish causation, and neither was specifically designed to evaluate red wine as a cholesterol intervention — so readers should interpret these findings with appropriate caution.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Immunometabolic dysregulation in depression predates illness onset and associ... | Other | 2025 | Neutral | 90 |
| Baseline Cardiometabolic Profiles and SARS-CoV-2 Risk in the UK Biobank | Other | 2020 | Supports | 85 |